Drug shortage: Ketorolac Tromethamine Injection (KETOROLAC TROMETHAMINE)
FDA lists 25 presentations as Current. Availability: Unavailable (12), Limited Availability (1), Available (12). Reason: Delay in shipping of the drug; Other. Companies: Alembic Pharmaceuticals, Sagent Pharmaceuticals, Fresenius Kabi USA, LLC, Hikma Pharmaceuticals USA, Inc., Gland Pharma Limited….
- Published by source
- 2018-03-23
- First seen by Reality Radar
- 2026-10-22
- Last verified
- 2026-10-22
Affected
- Manufacturer
- Alembic Pharmaceuticals
- Products
- Ketorolac Tromethamine Injection KETOROLAC TROMETHAMINE
Whether your exact unit is affected depends on the model, serial number and region in the official notice.
What the official notice says
Risk: Current — Unavailable
Remedy / actions:
- Estimated recovery: end-October to mid-November 2026
- Estimated recovery: TBD
Is this affecting you?
Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.
Sources
- openFDA Drug Shortages Tier A · official published 2018-03-23
Evidence ledger
Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.
| Entry | Kind | Observed | Evidence hash | Entry hash |
|---|---|---|---|---|
| #906 | new | 2026-10-22 | c84f15175a56…7c6ccd | 94c28c9d86a0…c2a3c5 |
Chain head: #1076 8ad5adc30b9b…88ce20